Drug intelligence / Profile preview

DWC-20141 + DWC-20142

Development stage
Unknown
Lead developer
Daewoong Pharmaceutical
Modality
Small Molecules
01

Overview

DWC-20141 and DWC-20142 are small molecule drugs developed by Daewoong Pharmaceutical. They have been studied both individually and in combination, primarily for the treatment of digestive system disorders, including gastroesophageal reflux disease (GERD), mouth and tooth diseases, and otorhinolaryngologic diseases. The combination has undergone pharmacokinetic and drug-drug interaction studies in healthy volunteers. As of the latest updates, their development status is preclinical or phase 1 with no reported approvals or advanced clinical data available[1][2][3].

Brand names
Plavixfexuprazan (no widely marketed brand names for the combination)
Other names
clopidogrel + DWP14012clopidogrel + fexuprazanclopidogrel + abeprazan
02

Targets

P2Y12 (Purinergic P2Y12 receptor)ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on DWC-20141 + DWC-20142.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DWC-20141 + DWC-20142.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call